These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

877 related items for PubMed ID: 1714403

  • 1. Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cells.
    Ottmann OG, Stella CC, Eder M, Reutzel P, Ströcker S, Hoelzer D, Ganser A.
    Exp Hematol; 1991 Sep; 19(8):773-8. PubMed ID: 1714403
    [Abstract] [Full Text] [Related]

  • 2. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM, Fortuna A, Fogli M, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [Abstract] [Full Text] [Related]

  • 4. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V.
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [Abstract] [Full Text] [Related]

  • 5. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 6. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 7. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L, Heimfeld S, Broxmeyer HE.
    Blood Cells; 1994 Sep; 20(2-3):436-54. PubMed ID: 7538350
    [Abstract] [Full Text] [Related]

  • 8. Human interleukin (IL)-9 specifically stimulates proliferation of CD34+++DR+CD33- erythroid progenitors in normal human bone marrow in the absence of serum.
    Lu L, Leemhuis T, Srour EF, Yang YC.
    Exp Hematol; 1992 May; 20(4):418-24. PubMed ID: 1373687
    [Abstract] [Full Text] [Related]

  • 9. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S.
    Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
    [Abstract] [Full Text] [Related]

  • 10. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C, Mangoni L, Almici C, Garau D, Craviotto L, Piovani G, Caramatti C, Rizzoli V.
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
    Traycoff CM, Abboud MR, Laver J, Brandt JE, Hoffman R, Law P, Ishizawa L, Srour EF.
    Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862
    [Abstract] [Full Text] [Related]

  • 14. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
    Reid CD, Stackpoole A, Meager A, Tikerpae J.
    J Immunol; 1992 Oct 15; 149(8):2681-8. PubMed ID: 1383322
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Human granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates immature marrow precursors but no CFU-GM, CFU-G, or CFU-M.
    Bot FJ, van Eijk L, Schipper P, Löwenberg B.
    Exp Hematol; 1989 Mar 15; 17(3):292-5. PubMed ID: 2645158
    [Abstract] [Full Text] [Related]

  • 17. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
    Ottmann OG, Abboud M, Welte K, Souza LM, Pelus LM.
    Exp Hematol; 1989 Feb 15; 17(2):191-7. PubMed ID: 2463933
    [Abstract] [Full Text] [Related]

  • 18. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z).
    Slavin S, Mumcuoglu M, Landesberg-Weisz A, Kedar E.
    Bone Marrow Transplant; 1989 Sep 15; 4(5):459-64. PubMed ID: 2676042
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.